CNBC's Kate Rogers discusses a news report that AMC is in talks to acquire Starz.
Greg Maffei, Liberty Interactive president & CEO discusses his company's $2.4 billion acquisition on Zulily.
The "Squawk Box" news team reports terms of the takeover deal.
Romit Shah, Nomura Securities, discusses Micron's takeover vulnerability, and why SanDisk could be next.
Anthem and Cigna are back in talks, according to sources, reports CNBC's David Faber.
An apparently fake bid for Avon is reportedly being reviewed by the SEC.
Rick Sherlund, Nomura Securities, shares his thoughts on rumors Microsoft may be mulling a potential bid for Salesforce.com, and weighs in on other contenders considering a cloud play.
Samad Samana, FBR Capital Markets, weighs in on potential suitors for Salesforce.com, and big tech's quest to conquer the cloud.
Oracle is the most likely buyer, says Samad Samana, FBR Capital Markets, sharing his thoughts on possible buyers for Salesforce.
Shares of Salesforce.com jumped on Wednesday amid a Bloomberg report that it is working with financial advisors to help with a potential takeover offer. Samad Samana, FBR VP research analyst, weighs in.
Reports say Endo International is making a takeover offer for Salix Pharmaceuticals. CNBC's David Faber has the details.
David Pyott, Allergan chairman & CEO, discusses the company's historic quarter, Bill Ackman's failed attempt to take over the company and the decision to subdivide the management team.
Sunac plans to buy a 49.3 percent stake in troubled Chinese developer Kaisa, which recently missed bond coupon payments, Caixin magazine reported.
Anil Doradla, William Blair & Company, shares his views on the smartphone maker's future after reports rise Samsung could be making a bid for the company.
Verizon CEO Lowell McAdam states AOL and other media companies are potential partners, but they are not in significant acquisition talks with AOL. CNBC's David Faber reports.
CNBC's David Faber reports Verizon has approached AOL about a potential joint venture or takeover.
Club Mediterrannee is expected to back an offer from a consortium led by Chinese billionaire Guo Guangchang, after a rival declined to raise his offer.
CNBC's Kate Kelly reveals what investors can expect from hedge funds and activists in 2015.
Leigh Drogen, Estimize CEO, discusses his "Mergerize" platform, and CNBC contributor Herb Greenberg, discuss if it is ever a good idea to invest in a company based on takeover speculation.
Michael Pearson, Valeant Pharmaceuticals CEO, shares his thoughts on allegations Allergan released false and misleading information.